Ubs Asset Management Americas Inc Ani Pharmaceuticals Inc Transaction History

Ubs Asset Management Americas Inc

$477 Billion
Q2 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 55,624 shares of ANIP stock, worth $4.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,624

Previous 48,322 15.11%

Holding current value

$4.99 Million

Previous $3.24 Million 12.18%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$57.79 - $72.95 $421,982 - $532,680	7,302 Added 15.11%	55,624 $3.63 Million
Q1 2025 May 19, 2025	BUY	$53.93 - $68.36 $22,812 - $28,916	423 Added 0.88%	48,322 $3.24 Million
Q4 2024 Feb 14, 2025	BUY	$53.35 - $61.74 $744,125 - $861,149	13,948 Added 41.08%	47,899 $2.65 Million
Q3 2024 Nov 14, 2024	SELL	$54.33 - $65.72 $490,056 - $592,794	-9,020 Reduced 20.99%	33,951 $2.03 Million
Q2 2024 Aug 13, 2024	BUY	$58.53 - $68.82 $1.61 Million - $1.89 Million	27,435 Added 176.59%	42,971 $2.74 Million
Q3 2023 Nov 13, 2023	BUY	$50.28 - $64.61 $270,657 - $347,795	5,383 Added 53.02%	15,536 $902,000
Q1 2023 May 15, 2023	BUY	$37.61 - $45.72 $190,344 - $231,388	5,061 Added 99.39%	10,153 $403,000
Q4 2022 Feb 14, 2023	SELL	$31.9 - $41.95 $44,436 - $58,436	-1,393 Reduced 21.48%	5,092 $204,000
Q3 2022 Nov 14, 2022	SELL	$29.83 - $38.01 $48,861 - $62,260	-1,638 Reduced 20.16%	6,485 $208,000
Q2 2022 Aug 12, 2022	BUY	$23.09 - $33.46 $11,868 - $17,198	514 Added 6.76%	8,123 $241,000
Q2 2021 Aug 16, 2021	BUY	$31.86 - $38.6 $26,348 - $31,922	827 Added 12.19%	7,609 $266,000
Q1 2021 May 14, 2021	BUY	$28.4 - $36.14 $192,608 - $245,101	6,782 New	6,782 $245,000
Q2 2020 Aug 14, 2020	SELL	$29.93 - $50.1 $171,977 - $287,874	-5,746 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$30.35 - $67.14 $8,103 - $17,926	-267 Reduced 4.44%	5,746 $234,000
Q4 2019 Feb 14, 2020	SELL	$55.65 - $79.83 $54,815 - $78,632	-985 Reduced 14.08%	6,013 $370,000
Q3 2019 Nov 14, 2019	BUY	$64.7 - $85.39 $100,414 - $132,525	1,552 Added 28.5%	6,998 $510,000
Q2 2019 Aug 15, 2019	BUY	$67.77 - $82.2 $44,457 - $53,923	656 Added 13.7%	5,446 $0
Q1 2019 May 14, 2019	BUY	$45.83 - $70.54 $180,936 - $278,491	3,948 Added 468.88%	4,790 $0
Q4 2018 Feb 13, 2019	BUY	$41.17 - $56.44 $34,665 - $47,522	842 New	842 $37,000

Others Institutions Holding ANIP

# of Institutions

243

Shares Held

20M

Call Options Held

19.9K

Put Options Held

12.8K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.56B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Ani Pharmaceuticals Inc Transaction History